Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention
2017/08/01 by Manuel Picon‐Ruiz, Cynthia Morata‐Tarifa, Janeiro J. Valle‐Goffin +3 · 28 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Cancer Risks and Factors #Metabolism, Diabetes, and Cancer #Cancer, Lipids, and Metabolism
paper · pdf · doi:10.3322/caac.21405
Abstract
Abstract Answer questions and earn CME/CNE Recent decades have seen an unprecedented rise in obesity, and the health impact thereof is increasingly evident. In 2014, worldwide, more than 1.9 billion adults were overweight (body mass index [BMI], 25‐29.9 kg/m 2 ), and of these, over 600 million were obese (BMI ≥30 kg/m 2 ). Although the association between obesity and the risk of diabetes and coronary artery disease is widely known, the impact of obesity on cancer incidence, morbidity, and mortality is not fully appreciated. Obesity is associated both with a higher risk of developing breast cancer, particularly in postmenopausal women, and with worse disease outcome for women of all ages. The first part of this review summarizes the relationships between obesity and breast cancer development and outcomes in premenopausal and postmenopausal women and in those with hormone receptor‐positive and ‐negative disease. The second part of this review addresses hypothesized molecular mechanistic insights that may underlie the effects of obesity to increase local and circulating proinflammatory cytokines, promote tumor angiogenesis and stimulate the most malignant cancer stem cell population to drive cancer growth, invasion, and metastasis. Finally, a review of observational studies demonstrates that increased physical activity is associated with lower breast cancer risk and better outcomes. The effects of recent lifestyle interventions to decrease sex steroids, insulin/insulin‐like growth factor‐1 pathway activation, and inflammatory biomarkers associated with worse breast cancer outcomes in obesity also are discussed. Although many observational studies indicate that exercise with weight loss is associated with improved breast cancer outcome, further prospective studies are needed to determine whether weight reduction will lead to improved patient outcomes. It is hoped that several ongoing lifestyle intervention trials, which are reviewed herein, will support the systematic incorporation of weight loss intervention strategies into care for patients with breast cancer. CA Cancer J Clin 2017;67:378–397. © 2017 The Authors. CA A Cancer Journal for Clinicians published by Wiley Periodicals, Inc. on behalf of American Cancer Society. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Citations
Cited by
- The obesity pandemic and its impact on non-communicable disease burden
- Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial
- Impact of exercise on health outcomes in people with cancer: an umbrella review of systematic reviews and meta-analyses of randomised controlled trials
- Association of Body Mass Index and Age With Subsequent Breast Cancer Risk in Premenopausal Women. [europepmc]
- Pooled Analysis of Nine Cohorts Reveals Breast Cancer Risk Factors by Tumor Molecular Subtype. [europepmc]
- Age-specific breast cancer risk by body mass index and familial risk: prospective family study cohort (ProF-SC). [europepmc]
- Adipose Tissue, Obesity and Adiponectin: Role in Endocrine Cancer Risk. [europepmc]
- The Effects of Adipocytes on the Regulation of Breast Cancer in the Tumor Microenvironment: An Update. [europepmc]
- The Obesity Paradox in Cancer, Tumor Immunology, and Immunotherapy: Potential Therapeutic Implications in Triple Negative Breast Cancer. [europepmc]
- Cancer-associated adipocytes: key players in breast cancer progression. [europepmc]
- Metabolic Health, Insulin, and Breast Cancer: Why Oncologists Should Care About Insulin. [europepmc]
- Flavonoids and Other Polyphenols Act as Epigenetic Modifiers in Breast Cancer. [europepmc]
- Probiotic Mixture of Lactobacillus plantarum Strains Improves Lipid Metabolism and Gut Microbiota Structure in High Fat Diet-Fed Mice. [europepmc]
- FABP4: A New Player in Obesity-Associated Breast Cancer. [europepmc]
- CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer. [europepmc]
- The Importance of Breast Adipose Tissue in Breast Cancer. [europepmc]
- Breast cancer risk factors and their effects on survival: a Mendelian randomisation study. [europepmc]
- Cancer-associated adipocytes as immunomodulators in cancer. [europepmc]
- Time-restricted feeding normalizes hyperinsulinemia to inhibit breast cancer in obese postmenopausal mouse models. [europepmc]
- Epidemiological trends of women's cancers from 1990 to 2019 at the global, regional, and national levels: a population-based study. [europepmc]
- Global breast cancer incidence and mortality trends by region, age-groups, and fertility patterns. [europepmc]
- Impacts and mechanisms of alternative mRNA splicing in cancer metabolism, immune response, and therapeutics. [europepmc]
- Breast Cancer-Epidemiology, Classification, Pathogenesis and Treatment (Review of Literature). [europepmc]
- Metabolic dysfunction and obesity-related cancer: Beyond obesity and metabolic syndrome. [europepmc]
- Advances in the Prevention and Treatment of Obesity-Driven Effects in Breast Cancers. [europepmc]
- Single cell atlas identifies lipid-processing and immunomodulatory endothelial cells in healthy and malignant breast. [europepmc]
- Postdiagnosis body fatness, weight change and breast cancer prognosis: Global Cancer Update Program (CUP global) systematic literature review and meta-analysis. [europepmc]
- A high-fat diet promotes cancer progression by inducing gut microbiota-mediated leucine production and PMN-MDSC differentiation. [europepmc]
Related